The research and development products of Pars Isotope have been updated…
Follow Us:
Pars Isotope’s Active Participation in the 31st National Nuclear Conference During…
The CEO of Pars Isotope at the closing ceremony of the…
The launch of Pars Isotope’s booth at the 25th Iranian Nuclear…
“The presence of Pars Isotope at the 25th Iranian Nuclear Medicine…
President Unveils Three New Radiopharmaceuticals by Pars Isotope at 19th National…
The successful presence of Pars Isotope at the 9th International Congress and…
The presence of Pars Isotope at the 18th International Congress of…
The presence of Pars Isotope at the 7th Conference on Measurement…
The presence of the Minister of Health and Medical Education at…
Mr. Mohammad Reza Aref, First Vice President, visits the achievements of…
Topical Rhenium-188 for Skin Cancer Treatment Skin cancer is one of…
Early 68 Ga-FAP-2286 PET Imaging The use of 68Ga–labeled inhibitors of fibroblast activation…
Pars Isotope in EANM timelines Our 13th participation in the most…
Follow The Variety this year in Hamburg introducing diverse and practical…
Updating of the general catalogue of pharmaceutical products (general) The general…
The members of the Program, Budget and Accounting Commission of the…
Image of the Month in the European Journal of Nuclear Medicine:…
A report on how to perform Process imaging in Tc-99m-Trodat radiopharmaceutical…
CEO of Pars Isotope at the BRICS 2024: Paying attention to…
A visual report of the first scientific symposium and gathering of…
The presence of Pars Isotope at the 17th International Breast Cancer…
CEO of Pars Isotope: We are moving on the frontier of…
Pars Isotope wishes all foreign business partners and colleagues a very…
The presence of Pars Isotope in the 24th Iranian Nuclear Medicine…
A meeting with the presence of nuclear medicine centers equipped with…
Pictures and news report of Pars Isotope’s presence at the 29th…
Holding a preclinical imaging conference With the special participation of Pars…
The Spanish Version of Pars Isotope’s website has been launched The…
The presence of Pars Isotope in the 29th Congress of the…
The presence of Pars Isotope in the Annual EANM Congress Pars…
Pictures and news reports from the Pars Isotope booth at the…
Presence of Pars Isotope Co. at the SASNM congress in South…
The new phantom manufactured by Pars Isotope Co. received approval from…
Obtaining a bilingual GMP certificate from Iran Food and Drug Administration…
Presence of Pars Isotope in the 6th International Cancer Congress Pars…
The presence of Pars Isotope Co. in International Symposium on Trends…
The presence of Pars Isotope in the international health exhibition of…
The Administrator of Drug and Controlled Substances Affairs of the Food…
Utilizing radiopharmaceuticals made by Pars Isotope Co. for the feasibility and…
Production of Pars-GalluGEN generator with the maximum amount of output activity…
Utilizing radiopharmaceuticals; prosperity of health diplomacy “Radiopharmaceutical technology is the prosperity…
Synthesis of the active ingredient of MDP radiopharmaceutical kit by Pars…
Photo album of Pars Isotope’s participation at the EANM 2022 exhibition…
Updates on Pars Isotope’s Pharmaceutical Products Catalog The latest catalog of…
The new version of Pars Isotope’s radiopharmaceutical kits catalog The latest…
Waving Pars Isotope’s Flag atop Mount Ararat Peak On August 8,…
The SNMMI 2022 International Best Abstract Award for Iran Abstract submitted…
The UN Special Rapporteur Paid a Visit to Pars Isotope .Co…
One-day seminar on “The role of radiopharmaceuticals in the diagnosis and…